SHL Telemedicine (SHLT) Competitors $2.31 -0.01 (-0.22%) As of 02/21/2025 03:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends SHLT vs. TOI, CCM, HIMS, TDOC, AUNA, SBC, AIRS, LFMD, LXEO, and ADAPShould you be buying SHL Telemedicine stock or one of its competitors? The main competitors of SHL Telemedicine include Oncology Institute (TOI), Concord Medical Services (CCM), Hims & Hers Health (HIMS), Teladoc Health (TDOC), Auna (AUNA), SBC Medical Group (SBC), AirSculpt Technologies (AIRS), LifeMD (LFMD), Lexeo Therapeutics (LXEO), and Adaptimmune Therapeutics (ADAP). SHL Telemedicine vs. Oncology Institute Concord Medical Services Hims & Hers Health Teladoc Health Auna SBC Medical Group AirSculpt Technologies LifeMD Lexeo Therapeutics Adaptimmune Therapeutics Oncology Institute (NASDAQ:TOI) and SHL Telemedicine (NASDAQ:SHLT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, community ranking, dividends, risk, institutional ownership, profitability and valuation. Which has more risk and volatility, TOI or SHLT? Oncology Institute has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Comparatively, SHL Telemedicine has a beta of -0.26, indicating that its share price is 126% less volatile than the S&P 500. Does the MarketBeat Community favor TOI or SHLT? Oncology Institute received 3 more outperform votes than SHL Telemedicine when rated by MarketBeat users. However, 100.00% of users gave SHL Telemedicine an outperform vote while only 66.67% of users gave Oncology Institute an outperform vote. CompanyUnderperformOutperformOncology InstituteOutperform Votes466.67% Underperform Votes233.33% SHL TelemedicineOutperform Votes1100.00% Underperform VotesNo Votes Do institutionals & insiders hold more shares of TOI or SHLT? 36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 20.1% of SHL Telemedicine shares are owned by institutional investors. 9.5% of Oncology Institute shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts recommend TOI or SHLT? Oncology Institute currently has a consensus price target of $2.50, suggesting a potential upside of 180.93%. SHL Telemedicine has a consensus price target of $11.00, suggesting a potential upside of 377.22%. Given SHL Telemedicine's higher possible upside, analysts plainly believe SHL Telemedicine is more favorable than Oncology Institute.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00SHL Telemedicine 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TOI or SHLT more profitable? SHL Telemedicine has a net margin of 0.00% compared to Oncology Institute's net margin of -17.63%. SHL Telemedicine's return on equity of 0.00% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-17.63% -186.83% -34.58% SHL Telemedicine N/A N/A N/A Which has higher earnings & valuation, TOI or SHLT? SHL Telemedicine has lower revenue, but higher earnings than Oncology Institute. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$324.24M0.21-$83.07M-$0.78-1.14SHL Telemedicine$57.08M0.66-$7.06MN/AN/A Does the media prefer TOI or SHLT? In the previous week, Oncology Institute had 1 more articles in the media than SHL Telemedicine. MarketBeat recorded 1 mentions for Oncology Institute and 0 mentions for SHL Telemedicine. Oncology Institute's average media sentiment score of 0.00 equaled SHL Telemedicine'saverage media sentiment score. Company Overall Sentiment Oncology Institute Neutral SHL Telemedicine Neutral SummarySHL Telemedicine beats Oncology Institute on 7 of the 13 factors compared between the two stocks. Get SHL Telemedicine News Delivered to You Automatically Sign up to receive the latest news and ratings for SHLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHLT vs. The Competition Export to ExcelMetricSHL TelemedicineOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.36M$2.06B$5.84B$9.15BDividend YieldN/AN/A4.75%3.85%P/E RatioN/A22.3226.1519.13Price / Sales0.662.24435.3370.72Price / Cash54.0336.6038.0134.83Price / Book0.4410.447.644.62Net Income-$7.06M-$52.07M$3.19B$245.94M7 Day Performance1.14%-10.51%-2.11%-2.62%1 Month Performance-17.53%9.99%-0.49%-2.15%1 Year Performance-63.70%31.25%16.44%12.95% SHL Telemedicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHLTSHL Telemedicine1.2872 of 5 stars$2.31-0.2%$11.00+377.2%-64.8%$38.36M$57.08M0.00583Gap UpTOIOncology Institute2.3988 of 5 stars$0.96+5.9%$2.50+160.1%-51.6%$72.62M$378.93M-1.23660News CoverageCCMConcord Medical Services0.6107 of 5 stars$4.77-1.6%N/A-36.2%$20.70M$75.69M0.00970Analyst ForecastNews CoverageGap DownHIMSHims & Hers Health2.6347 of 5 stars$60.41+2.1%$25.13-58.4%+422.3%$13.20B$872M137.311,046Analyst DowngradeInsider TradeNews CoverageGap DownHigh Trading VolumeTDOCTeladoc Health2.0292 of 5 stars$14.36+6.3%$12.08-15.9%-26.4%$2.47B$2.60B-2.495,600Analyst ForecastNews CoverageGap UpHigh Trading VolumeAUNAAuna3.4171 of 5 stars$8.62-1.1%$13.53+56.9%N/A$637.19M$1.04B0.0014,958SBCSBC Medical GroupN/A$4.78-6.3%N/AN/A$492.44MN/A0.00N/AGap UpHigh Trading VolumeAIRSAirSculpt Technologies0.2434 of 5 stars$5.76-4.0%$5.00-13.2%-15.2%$333.40M$188.78M-41.14240LFMDLifeMD1.8883 of 5 stars$7.66+5.4%$11.14+45.5%-23.3%$331.76M$152.55M-11.97230Insider TradeNews CoverageHigh Trading VolumeLXEOLexeo Therapeutics3.3526 of 5 stars$4.50+6.6%$23.80+428.9%-74.8%$148.82M$650,000.00-1.4258News CoverageGap UpADAPAdaptimmune Therapeutics2.3279 of 5 stars$0.58+0.3%$2.79+382.3%-62.7%$147.90M$60.28M-2.63490Positive News Related Companies and Tools Related Companies TOI Competitors CCM Competitors HIMS Competitors TDOC Competitors AUNA Competitors SBC Competitors AIRS Competitors LFMD Competitors LXEO Competitors ADAP Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SHLT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SHL Telemedicine Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share SHL Telemedicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
